<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs are now recognized as important regulators of cardiovascular genes with critical roles in <z:mpath ids='MPATH_458'>normal</z:mpath> development and <z:mp ids='MP_0001532'>physiology</z:mp>, as well as disease development </plain></SENT>
<SENT sid="1" pm="."><plain>MicroRNAs (miRNAs) are small noncoding <z:chebi fb="40" ids="33697">RNAs</z:chebi> approximately 22 nucleotides in length that regulate expression of target genes through sequence-specific hybridization to the 3' untranslated region of <z:chebi fb="5" ids="33699">messenger RNAs</z:chebi> and either block translation or direct degradation of their target <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>They have been shown to participate in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> pathogenesis including <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0001635'>heart failure</z:hpo>, and <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Broadly defined, <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> are a variation from the <z:mpath ids='MPATH_458'>normal</z:mpath> heart rate or rhythm </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011675'>Arrhythmias</z:hpo> are common and result in significant morbidity and mortality </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0004308'>Ventricular arrhythmias</z:hpo> constitute a major cause for cardiac <z:hpo ids='HP_0011420'>death</z:hpo>, particularly <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> in the setting of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>As advances in pharmacologic, device, and ablative therapy continue to evolve, the molecular insights into the basis of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> is growing with the ambition of providing additional therapeutic options </plain></SENT>
<SENT sid="7" pm="."><plain>Electrical remodeling and structural remodeling are identified mechanisms underlying <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> generation; however, published studies focusing on miRNAs and cardiac conduction are sparse </plain></SENT>
<SENT sid="8" pm="."><plain>Recent studies have highlighted the role of miRNAs in cardiac rhythm through regulation of key ion channels, transporters, and cellular proteins in arrhythmogenic conditions </plain></SENT>
<SENT sid="9" pm="."><plain>This article aims to review the studies linking miRNAs to cardiac excitability and other processes pertinent to <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
</text></document>